Multiple Myeloma

Multiple myeloma is a cancer of plasma cells which are a type of white blood cells. Some of the most common symptoms and signs are elevated calcium, renal failure, anemia and bone lesions. Opportunistic infections are also typical in those with multiple myeloma. Treatment options include targeted therapy, chemotherapy, biological therapy, radiotherapy or bone marrow transplantation. 

Colorectal cancer, which develops in the large intestine, begins with small, noncancerous clump of cells, known as polyps, that form on the inside of …

Enhancing the efficacy of proteasome inhibitors (PI) is a central goal in myeloma therapy. We proposed that signaling-level responses after PI may …

The evolution and progression of multiple myeloma and its precursors over time is poorly understood. Here, we investigate the landscape and timing of …

Sutro Biopharma (STRO) is a clinical-stage biotechnology company that uses its XpressCF and XpressCF+ platforms to create next-generation protein …

A new test can identify patients with multiple myeloma (MM) who have a high-risk genetic profile as well as multiple chromosomal abnormalities. In …

Daratumumab (Dara), a multiple myeloma (MM) therapy, is an antibody against the surface receptor CD38, which is expressed not only on plasma cells …

Revenues: 8,973M (+6.9%); Pharmaceuticals: 6,764M (+8.1%); Consumer Healthcare: 1,300M (+3.3%); Vaccines: 900M (+3.1%).Net Income: 1,683M (+48.0%); …

Norton Healthcare has enrolled its first patient in a phase 2 trial to test the efficacy and safety of a cancer drug owned by Newton, …

Submit Post

By posting to this website and replying to posts you agree to these rules.